DYN($3.4B) has a higher market cap than RZLT($406M). RZLT YTD gains are higher at: 78.814 vs. DYN (-6.902). RZLT has higher annual earnings (EBITDA): -87.22M vs. DYN (-502.36M). DYN has more cash in the bank: 898M vs. RZLT (120M). RZLT has less debt than DYN: RZLT (1.11M) vs DYN (219M). DYN (0) and RZLT (0) have equivalent revenues.

	DYN	RZLT	DYN / RZLT
Capitalization	3.4B	406M	838%
EBITDA	-502.36M	-87.22M	576%
Gain YTD	-6.902	78.814	-9%
P/E Ratio	N/A	N/A	-
Revenue	0	0	-
Total Cash	898M	120M	748%
Total Debt	219M	1.11M	19,712%

FUNDAMENTALS RATINGS

DYN vs RZLT: Fundamental Ratings

	DYN	RZLT
OUTLOOK RATING 1..100	51	93
VALUATION overvalued / fair valued / undervalued 1..100	36 Fair valued	30 Undervalued
PROFIT vs RISK RATING 1..100	97	100
SMR RATING 1..100	98	98
PRICE GROWTH RATING 1..100	61	51
P/E GROWTH RATING 1..100	100	100
SEASONALITY SCORE 1..100	24	50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RZLT's Valuation (30) in the null industry is in the same range as DYN (36) in the Electric Utilities industry. This means that RZLT’s stock grew similarly to DYN’s over the last 12 months.

DYN's Profit vs Risk Rating (97) in the Electric Utilities industry is in the same range as RZLT (100) in the null industry. This means that DYN’s stock grew similarly to RZLT’s over the last 12 months.

DYN's SMR Rating (98) in the Electric Utilities industry is in the same range as RZLT (98) in the null industry. This means that DYN’s stock grew similarly to RZLT’s over the last 12 months.

RZLT's Price Growth Rating (51) in the null industry is in the same range as DYN (61) in the Electric Utilities industry. This means that RZLT’s stock grew similarly to DYN’s over the last 12 months.

RZLT's P/E Growth Rating (100) in the null industry is in the same range as DYN (100) in the Electric Utilities industry. This means that RZLT’s stock grew similarly to DYN’s over the last 12 months.

TECHNICAL ANALYSIS

Technical Analysis

	DYN	RZLT
RSI ODDS (%)	2 days ago 81%	2 days ago 82%
Stochastic ODDS (%)	2 days ago 79%	2 days ago 90%
Momentum ODDS (%)	2 days ago 90%	2 days ago 84%
MACD ODDS (%)	5 days ago 88%	2 days ago 82%
TrendWeek ODDS (%)	2 days ago 85%	2 days ago 88%
TrendMonth ODDS (%)	2 days ago 86%	2 days ago 90%
Advances ODDS (%)	18 days ago 85%	2 days ago 90%
Declines ODDS (%)	2 days ago 85%	4 days ago 87%
BollingerBands ODDS (%)	2 days ago 78%	2 days ago 88%
Aroon ODDS (%)	2 days ago 83%	N/A

COMPARISON

Comparison

Sep 12, 2026

Stock price -- (DYN: $18.21 vs. RZLT: $4.22)

Brand notoriety: DYN and RZLT are both not notable

Both companies represent the Biotechnology industry

Current volume relative to the 65-day Moving Average: DYN: 148% vs. RZLT: 101%

Market capitalization -- DYN: $3.4B vs. RZLT: $406.35M

DYN [@Biotechnology] is valued at $3.4B. RZLT’s [@Biotechnology] market capitalization is $406.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 0 FA rating(s) are green while RZLT’s FA Score has 1 green FA rating(s).

DYN’s FA Score: 0 green, 5 red.
RZLT’s FA Score: 1 green, 4 red.

According to our system of comparison, both DYN and RZLT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 4 TA indicator(s) are bullish while RZLT’s TA Score has 5 bullish TA indicator(s).

DYN’s TA Score: 4 bullish, 6 bearish.
RZLT’s TA Score: 5 bullish, 5 bearish.

According to our system of comparison, RZLT is a better buy in the short-term than DYN.

Price Growth

DYN (@Biotechnology) experienced а -25.00% price change this week, while RZLT (@Biotechnology) price change was -7.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

DYN is expected to report earnings on Oct 29, 2026.

RZLT is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three

DYN

Daily Signal:

Gain/Loss:

RZLT

Setup

Daily Signal:

Description

Gain/Loss:

NEWBiotechnologies - Trading Results
AI Trading Agent, 60min NEWBiotechnologies - Trading Results
AI Trading Agent, 60min

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

Interact to see
Advertisement

Interesting Tickers

MFs / NAME	Price $	Chg $	Chg %
		1 Day
JGVRX	43.83	N/A	N/A
JPMorgan Growth Advantage R5
WFEMX	24.12	N/A	N/A
WCM Focused Emerging Markets Investor
HFMVX	29.63	N/A	N/A
Hartford MidCap R6
IWTTX	12.89	N/A	N/A
Voya Global High Dividend Low Vol PortS2
BBTGX	45.30	N/A	N/A
Sterling Capital Behav Lg Cp Val Eq A

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with RNA. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then RNA could also see price increases.

Ticker / NAME	Correlation To DYN	1D Price Change %
DYN	100%	-1.14%
RNA - DYN	64% Loosely correlated	+0.10%
RCKT - DYN	47% Loosely correlated	-3.74%
BBIO - DYN	46% Loosely correlated	-0.08%
IDYA - DYN	45% Loosely correlated	+0.37%
CLDX - DYN	45% Loosely correlated	-3.15%
More

RZLT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RZLT has been loosely correlated with GRI. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if RZLT jumps, then GRI could also see price increases.

Ticker / NAME	Correlation To RZLT	1D Price Change %
RZLT	100%	+1.20%
GRI - RZLT	52% Loosely correlated	-2.06%
DYN - RZLT	43% Loosely correlated	-1.14%
SYRE - RZLT	42% Loosely correlated	+2.13%
CRVS - RZLT	41% Loosely correlated	-0.23%
IDYA - RZLT	41% Loosely correlated	+0.37%
More